secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOREGENX, INC. (BRGX)
CIK:        0001593184
Form:       8-K
Filed at:   2024-06-11T23:59:59+00:00
Accession:  0001683168-24-004095
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 4.01, 4.02
LLM model:  deepseek-v4-flash:cloud@v2

BioRegenx restates Q1 2024 financials; appoints Weinberg & Co. as new auditor
-----------------------------------------------------------------------------

- Engaged Weinberg & Company as new independent accountant for fiscal years ended Dec 31, 2023 and 2022, effective June 10, 2024.
- Concluded Q1 2024 Form 10-Q and 10-Q/A should no longer be relied upon due to lack of auditor review prior to filing.
- Management evaluating restatement impact on financials and internal controls; will file amended 10-Q/A as soon as practical.
- No prior consultations with Weinberg on accounting principles or disagreements during past two fiscal years and subsequent interim period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1593184/000168316824004095/0001683168-24-004095-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1593184/000168316824004095/bioregenx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-004095

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer